Nasrin Sarafan‐Vasseur

Early Evaluation of Circulating Tumor DNA as Marker of Therapeutic Efficacy in Metastatic Colorectal Cancer Patients (PLACOL Study)

Fanny Garlan, Pierre Laurent‐Puig, David Sefrioui et al. · Clinical Cancer Research · 2017 · 243 citations · Full text

Diagnostic value of CA19.9, circulating tumour DNA and circulating tumour cells in patients with solid pancreatic tumours

David Sefrioui, France Blanchard, Emmanuel Touré et al. · British Journal of Cancer · 2017 · 116 citations · Full text

Kinetics, prognostic and predictive values of <i>ESR1</i> circulating mutations in metastatic breast cancer patients progressing on aromatase inhibitor

Florian Clatot, Anne Perdrix, Laetitia Augusto et al. · Oncotarget · 2016 · 95 citations · Full text

Gradual reduction of BUBR1 protein levels results in premature sister-chromatid separation then in aneuploidy

Élodie Bohers, Nasrin Sarafan‐Vasseur, Aurélie Drouet et al. · Human Genetics · 2008 · 94 citations

Chromatin, Genome Instability, Cell Division +11

Short report: Monitoring <scp><i>ESR</i></scp><i>1</i> mutations by circulating tumor <scp>DNA</scp> in aromatase inhibitor resistant metastatic breast cancer

David Sefrioui, Anne Perdrix, Nasrin Sarafan‐Vasseur et al. · International Journal of Cancer · 2015 · 82 citations · Full text

Breast Oncology, Engineering, Clear Esr1 Mutation +19